Test of fast-pacing therapy for congenital heart rhythm issues
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial studies whether a device-based fast pacing therapy (called ATP) can better treat certain rapid heart rhythm problems in people born with a heart condition. It may help prevent or reduce episodes of atrial (upper-chamber) arrhythmias that occur despite having a pacing/defibrillator device.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were born with a heart structure problem (congenital heart disease).
- You have an atrial rhythm problem (a fast or irregular rhythm in the upper chambers).
- You have an implanted device for atrial tachycardia therapy (an ATD).
- Your device’s fast-pacing therapy (ATP) must be turned on.
- You have not had heart transplant, surgical maze surgery, or ablation within 5 years of your ATD implant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new catheter (a thin tube that goes into the heart) to map and treat fast heart rhythms. It may be an option for people with certain types of heart rhythm problems who are scheduled for a catheter ablation procedure.
This trial tests a procedure to “ablate” (treat) a specific fast heart rhythm in the upper chambers of the heart that happens after previous atrial fibrillation (AF) ablation or heart surgery. It may help by stopping the rhythm and reducing symptoms, while doctors check how well the targeted mapping and ablation work.
This study is testing two new ways of pacing the heart to see if they can reduce the chance of developing atrial fibrillation (an irregular heartbeat). It might be a good fit if you need a pacemaker for a slow heart rate but have never had atrial fibrillation before.
This trial studies whether a special type of pacing (stimulating the heart's natural electrical system) works better than standard pacing after a procedure to control very fast heart rhythms. It's for people who already have a pacemaker and are getting a specific treatment for atrial fibrillation.
This trial studies whether a strategy to regularize (control) heart rate can improve outcomes in people who have permanent atrial fibrillation and heart failure. It focuses on people with recent heart-failure hospitalization and checks several heart, kidney, and health-condition limits to keep the study safe.
This trial tests whether starting treatment early to control your heart's rhythm can help people with a heart device who have short bursts of a fast heartbeat (called atrial high rate episodes) but haven't yet been diagnosed with atrial fibrillation on a standard EKG or Holter monitor.
Hear when a new Atrial Arrhythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.